Enlivex Therapeutics Ltd.

NASDAQ:ENLV

1.195 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 0.92647.82211.2025.6733.9489.7363.5266.8717.28610.5835.550.146
Short Term Investments 26.5070.29972.92830.0348.060.0403.00712.04622.02800
Cash and Short Term Investments 27.43348.12184.1335.70712.0089.7763.5266.8717.28610.5835.550.146
Net Receivables 0.2290.6472.1991.1642.4030.2130.0280.6631.060.2740.1290.01
Inventory -0.2291.177-12.203-31.1981.50000000
Other Current Assets 6.3312.38512.31632.4480.510.2880.0683.00712.04622.02800
Total Current Assets 33.76452.3386.44238.12116.42110.2773.62210.54120.39232.8855.6790.156
Non-Current Assets:
Property, Plant & Equipment, Net 2.5814.98.2192.141.0580.68500.0710.0910.060.0020
Goodwill 000000000000
Intangible Assets 00000.410000000
Goodwill and Intangible Assets 00000.410000000
Long Term Investments 0.3080.3070.0030.0890.0760.05600.0110.033000
Tax Assets 0000-0.0760000000
Other Non-Current Assets 0.1790.1050.4820.008-0.3290.01600.00700.0090.0050
Total Non-Current Assets 3.06715.3128.7042.2371.1390.75700.0890.1240.0690.0070
Total Assets 36.83167.64295.14640.35817.5611.0343.62210.6320.51632.9545.6860.156
Liabilities & Equity:
Current Liabilities:
Account Payables 0.8271.9480.8780.4630.3160.1730.0190.71.4122.280.0460.074
Short Term Debt 0.3460.6530.6170.2030.1230000000
Tax Payables 000000.222000000
Deferred Revenue 000000000000
Other Current Liabilities 4.0612.0582.3453.2435.2250.5620.4220.531-0.31-2.280.039-0.067
Total Current Liabilities 6.0616.6074.7184.3725.981.130.461.9312.5142.280.1310.081
Non-Current Liabilities:
Long Term Debt 0.6864.1945.389000000000
Deferred Revenue Non-Current 000000000000
Deferred Tax Liabilities Non-Current 000000000000
Other Non-Current Liabilities 0000.4990.2980.198000.07000
Total Non-Current Liabilities 0.6864.1945.3890.4990.2980.198000.07000
Total Liabilities 6.74710.80110.1074.8716.2781.3280.461.9312.5842.280.1310.081
Equity:
Preferred Stock 000000.5240.00100000.001
Common Stock 2.1372.1172.1071.6461.1510.3960.0450.0450.0390.0390.0290.02
Retained Earnings -112.093-83.025-51.965-37.497-25.673-16.289-45.754-39.809-23.787-8.422-1.4-0.229
Accumulated Other Comprehensive Income/Loss 1.1011.1011.1010.977-1.3-2.251-0.002-0.04-0.022-0.00500
Other Total Stockholders Equity 138.939136.648133.79670.36137.10427.32648.87248.50341.70239.0626.9260.283
Total Shareholders Equity 30.08456.84185.03935.48711.2829.7063.1628.69917.93230.6745.5550.075
Total Equity 30.08456.84185.03935.48711.2829.7063.1628.69917.93230.6745.5550.075
Total Liabilities & Shareholders Equity 36.83167.64295.14640.35817.5611.0343.62210.6320.51632.9545.6860.156